Adam Boynton (Postdoctoral Fellow)
Adam received his BS with honors in chemistry from Trinity College (’12), where he worked in the lab of Dr. Tim Curran exploring the coordination of tungsten to diphenylacetylene ß-turn peptidomimetics. He then pursued a PhD in chemistry at Caltech (’17) under the mentorship of Dr. Jackie Barton. While at Caltech, Adam studied luminescent ruthenium complexes that function as “light switch” probes for DNA mismatches. Adam is currently studying approaches to therapeutically target cancers that harbor mutations in the Mismatch Repair pathway.
Fun fact: Adam’s passions expand beyond the lab and include weightlifting, hot yoga, singing acappella, heading to the ballpark for a game, and visiting craft breweries.
Graham Buchan (Research Associate)
Graham received his BA with honors in biology from Williams College. As an undergraduate researcher, Graham studied the genetic link between dopamine signaling and arousal state in Drosophila. Graham was also the varsity captain of the Williams College men’s crew rowing team. In the Bandopadhayay Lab, Graham is characterizing the mechanism through which fusion proteins contribute to the formation of pediatric low-grade gliomas.
Alexandra ‘Larisa’ Condurat (Postdoctoral Fellow)
Larisa received her B.Sc. degree in experimental biology from the University of Bucharest-Romania in 2011, where she investigated the importance of specific nucleotide polymorphisms in breast cancer patients. During her B.Sc studies, she did an Erasmus exchange semester at the University Paris Diderot. In 2013, she obtained her M.Sc degree in cancer biology, with a focus on oncolytic virotherapy of cancer, from the University of Heidelberg and the German Cancer Research Center (DKFZ). Larisa earned her PhD in 2018 from the Freiburg University in Germany, where she investigated the role of the Hippo/YAP-TAZ signaling pathway in neural crest development and neuroblastoma progression under the mentorship of Dr. Jan Pruszak. In the Bandopadhayay lab, Larisa is studying approaches to identify drivers of pediatric gliomas, and to develop novel therapeutic strategies to target them.
Yohanna Georgis (Undergraduate student)
Yohanna is an undergraduate student at Tufts University. She is currently studying PPM1D as a therapeutic target for DIPG. She is specifically interested in the effects of a truncating mutation in PPM1D as a contributor to cellular resistance to treatment, and in determining if this mutation in PPM1D is oncogenic in DIPG.
Fun fact: Yohanna and Beyoncé share a birthday.
Gabrielle ‘Gabi’ Gionet (Research Associate)
Gabi is a Denver native, and recent Boston transplant. So far, she is enjoying kayaking on the Charles River and cheering on the Bruins hockey team. Gabi graduated from McGill University as a double major in Molecular Biology and English. In the Bandopadhayay Lab, Gabi is investigating molecular dependencies in medulloblastoma. She hopes this work could lead to a cancer treatment which can be made financially accessible to sick children around the world.
Fun fact: Gabi has correctly spelled the word ‘fluorescent’ three times in her life.
Elizabeth ‘Eli’ Gonzalez (Research Associate)
Eli majored in molecular and cell biology at the University of Pennsylvania and is originally from Miami, Florida. She aspires to be a physician scientist and join the efforts to discover better treatments for rare pediatric cancers. As a research assistant in the Bandopadhayay Lab, Eli is developing strategies to uncover genomic dependencies of pediatric brain tumors. She is also interested in science diplomacy, particularly collaborations on cancer research between the US and Cuba.
Fun fact: Eli loves to snorkel, and her favorite animal is a Yellowtail Damselfish.
Spandana Jarmale (Undergraduate student)
Spandana is a Junior at Brown University studying Neuroscience. She has spent the past year researching biomarkers of Alzheimer’s and its presentation in patients. She is interested in the transition of the brain from healthy to pathological and hopes to apply this to understand how pediatric brain tumors develop.
Fun fact: Spandana has been skydiving and loves traveling and exploring the world. One of her favorite things to do is Bhartanatyam, an Indian style of classical dance
Prasidda Khadka (Graduate student)
Prasidda received his BA in biology and biochemistry from Carleton College in Northfield, Minnesota, before joining the BBS PhD program at Harvard University in 2016. In the Bandopadhayay Lab, Prasidda is currently studying the role of PPM1D mutations in the pathogenesis of Diffuse Intrinsic Pontine Glioma (DIPG). Prasidda is co-mentored by Drs. Bandopadhayay and Beroukhim.
Zach Reitman (Postdoctoral Fellow)
Zach was born in Glenmoore, Pennsylvania (outside Philadelphia). He studied biochemistry and molecular biology at Penn State (’06), and then pursued an MD/PhD at Duke University in Durham, North Carolina (’14). At Duke, Zach earned his PhD under the mentorship of Professor Hai Yan on research in the Tisch Brain Tumor Center revolving around gliomas and cancer-associated mutations in IDH1, TERT, PPM1D, ATRX, and several other very interesting genes. His research aimed at better classifying cancers to select appropriate treatments, and on identifying targets for new therapies for these brain tumors. Zach then spent a year in Baltimore at Union Memorial Hospital doing a preliminary year in internal medicine. He is now specializing into radiation oncology as a resident in the Harvard Radiation Oncology Program (’19). Zach aims to pursue a career as a physician-scientist, and sees himself treating patients with radiation therapy in the clinic while looking for ways to better understand the enemy (cancer) and improve the standard of care in the lab. Zach is co-mentored by Drs. Bandopadhayay and Beroukhim.
Fun fact: When he is not pipetting or fielding pages, Zach enjoys cycling, hiking, microbrewed beer, and Penn State and Philadelphia Eagles football. He likes spending time with his wife, Denise, and their two cats, Wink and Arya.
Kenin ‘Kenny’ Qian (Research Associate)
Kenny received his BA from Northwestern University in Integrated Science and in Biological Sciences. At Northwestern, he completed his honors thesis on genomic editing using CRISPR/Cas9 through gene knock outs, knock ins, and genome wide screens. In the Bandopadhayay Lab, Kenny is studying methods to target Glioblastomas that contain alterations in the Mismatch Repair Pathway.
Fun fact: Kenny was bald until the age of 18.